From: Role of MRI in diagnosis of prostate cancer and correlation of results with transrectal ultrasound guided biopsy “TRUS”
MRI T2W
Biopsy
Total
Malignant
Benign
Lesion
18 (60.0%) TP
5 (16.7%) FP
23 (76.7%)
No lesion
4 (13.3%) FN
3 (10.0%) TN
7 (23.3%)
22 (73.3%)
8 (26.7%)
30 (100.0%)
Kappa (95% CI)
0.201 (0.000–0.584)
P
0.269